Safety of rhythm control and cardioversion for patients with recurrent symptomatic atrial fibrillation in the absence of anticoagulation following percutaneous left atrial appendage occlusion

For patients with atrial fibrillation (AF) and contraindication to anticoagulation, percutaneous left atrial appendage occlusion (pLAAO) followed by immediate antiplatelet therapy is a proposed method to reduce both stroke (CVA) and hemorrhagic complications. In such patients who have undergone